Enterprise Europe Network
HomeParticipantsMarketplace

InvestmentUpdated on 9 November 2025

Investment opportunity in personalized midlife health

Founder | Perimenopause | Women's Health at TEVIA®

Marghita, Romania

About

Early-stage digital health initiative focused on optimizing women’s wellbeing during hormonal transition, through data-driven personalization and clinically validated solutions.

The project aims to build partnerships with investors and innovation funds supporting scalable models that integrate digital assessment, clinical research and applied nutraceutical development.

Objectives include accelerating validation, expanding scientific collaborations and preparing for international market entry.

Stage

  • Seed and Development
  • Startup

Applies to

  • BIOLOGY / BIOTECHNOLOGY
  • E-HEALTH
  • INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES
  • LIFE SCIENCE
  • THERAPEUTIC AREA

Organisation

TEVIA®

Digital Health Provider

Marghita, Romania

Similar opportunities

  • Project cooperation

    Clinical and research partnerships in women’s health

    • Strategic Partner
    • Technological contribution
    • Finding Partners - Completing consortia

    Camelia Ghiulai

    Founder | Perimenopause | Women's Health at TEVIA®

    Marghita, Romania

  • Investment

    Bioreplica Spinal Device

    • Startup
    • Seed and Development
    • BIOLOGY / BIOTECHNOLOGY
    • INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES

    Rodrigo de Pablos

    CEO at Bioreplica

    Las Palmas, Spain

  • Service

    COMPLIANCE ASSURANCE

    • Certification
    • INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES

    Barend Smet

    President at Thaumatec Tech Group

    Poland